Cite

HARVARD Citation

    Liu, M. et al. (n.d.). IDDF2019-ABS-0174 Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma. Gut. pp. A2-A3. [Online]. 
  
Back to record